search
Back to results

Treating Acute MI Patients With Aggrastat on Their Way to Hospital

Primary Purpose

Acute Myocardial Infarction

Status
Unknown status
Phase
Phase 4
Locations
Israel
Study Type
Interventional
Intervention
Tirofiban
Sponsored by
The Baruch Padeh Medical Center, Poriya
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Myocardial Infarction

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: patients with acute Myocardial infarction with ST elevation , and moving by ambulance to Poriya hospital Exclusion Criteria: women less than 50 years old and 80 years old, bleeding tendency, stroke in the past

Sites / Locations

  • Cardiovascular Division, The Baruch Padeh Medical Center, Poriya,Recruiting
  • Magen David ,Recruiting

Outcomes

Primary Outcome Measures

mortality

Secondary Outcome Measures

TIMI flow
feeling better

Full Information

First Posted
March 1, 2006
Last Updated
August 10, 2011
Sponsor
The Baruch Padeh Medical Center, Poriya
search

1. Study Identification

Unique Protocol Identification Number
NCT00300833
Brief Title
Treating Acute MI Patients With Aggrastat on Their Way to Hospital
Study Type
Interventional

2. Study Status

Record Verification Date
January 2009
Overall Recruitment Status
Unknown status
Study Start Date
January 2006 (undefined)
Primary Completion Date
January 2012 (Anticipated)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
The Baruch Padeh Medical Center, Poriya

4. Oversight

5. Study Description

Brief Summary
Treating an AMI patient with ST elevation with Aggrastat in the ambulance on his or her way to the hospital.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Myocardial Infarction

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Tirofiban
Intervention Description
pci
Primary Outcome Measure Information:
Title
mortality
Time Frame
immidiately
Secondary Outcome Measure Information:
Title
TIMI flow
Description
feeling better
Time Frame
24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients with acute Myocardial infarction with ST elevation , and moving by ambulance to Poriya hospital Exclusion Criteria: women less than 50 years old and 80 years old, bleeding tendency, stroke in the past
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yonathan Hasin, Professor
Phone
97246652648
Email
yhasin@poria.health.gov.il
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Menachem Naheer
Organizational Affiliation
The Baruch Padeh Medicel Center, Poriya, Tiberias, Israel
Official's Role
Study Chair
Facility Information:
Facility Name
Cardiovascular Division, The Baruch Padeh Medical Center, Poriya,
City
Tiberias
ZIP/Postal Code
15208
Country
Israel
Individual Site Status
Recruiting
Facility Name
Magen David ,
City
Tiberias
Country
Israel
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sergay Krablikov, Dr

12. IPD Sharing Statement

Learn more about this trial

Treating Acute MI Patients With Aggrastat on Their Way to Hospital

We'll reach out to this number within 24 hrs